Question

The nurse is educating a client with end-stage renal failure about newly prescribed aluminum hydroxide. Which statement should the nurse include in the teaching?

"This medication binds with phosphates from food to decrease absorption."

"This medication is used to decrease urea to prevent urticaria."

"This medication will coat the lining of the stomach to decrease acid production."

"This medication treats hyperkalemia by exchanging sodium for potassium in the intestines."

Answer 1

The nurse should tell the client that aluminum hydroxide binds with phosphates from food to decrease their absorption in patients with end-stage renal failure. The correct option is 1).

Step-by-step explanation:

The correct statement that the nurse should include in teaching a client with end-stage renal failure about the medication aluminum hydroxide is: "This medication binds with phosphates from food to decrease absorption."

Aluminum hydroxide acts as a phosphate binder in patients with chronic kidney disease to help control hyperphosphatemia, a common problem in end-stage renal failure when the kidneys are less able to excrete phosphate.

It does not specifically target urea or urticaria, nor is it used primarily to coat the stomach lining to decrease acid production as antacids do. Additionally, aluminum hydroxide does not treat hyperkalemia by exchanging sodium for potassium in the intestines; other medications are designed for that purpose. Option 1) is the correct one.